Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,328.00
Bid: 2,323.00
Ask: 2,325.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.086%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,328.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

21 Sep 2023 07:00

RNS Number : 1335N
Halma PLC
21 September 2023
 

Trading update

 

Halma, the global group of life-saving technology companies focused on growing a safer, cleaner and healthier future, today releases its scheduled trading update ahead of its half year end on 30 September 2023.

Further progress in the first half and unchanged guidance for the full year

We have made further progress in the first half of this financial year despite varied market conditions. Our guidance for the full year to March 2024, for good organic constant currency1 revenue growth and Return on Sales2 of approximately 20%, is unchanged from that given in our results announcement in June3.

We expect the balance of revenue and Adjusted profit before taxation4 between the first and second half of this financial year to be in line with pre-COVID historical averages5.

Accordingly, in the first half of the year, we expect good organic constant currency1 revenue growth against a strong comparative period last year, and Return on Sales2 towards the lower end of our target range.

Our cash performance is enabling continued investment, both organically and in acquisitions, to expand our opportunities for growth over the medium to longer term.

Continued progress in varied market conditions

We continue to benefit from the strength and relevance of our purpose, the agility and entrepreneurialism which we derive from our Sustainable Growth Model, and the diversity and global reach of our portfolio. These are enabling us to deliver continued progress in varied market conditions.

Group order intake is ahead of the comparable period last year and close to revenue in the year to date. Order intake in the Safety and Environmental & Analysis sectors is in line with revenue; the Healthcare sector has experienced slower order intake, with the effects of recovery from post-COVID disruptions resulting in destocking by OEM customers and budgetary pressures at healthcare providers.

Revenue by sector on an organic constant currency1 basis reflects order book trends, with stronger growth in the Safety and Environmental & Analysis sectors, and similar revenue to the first half of last year in the Healthcare sector. All sectors will benefit from recent acquisitions.

Return on Sales2 in the Safety and Healthcare sectors is expected to be higher in the first half of the year, relative to the comparable period last year. The Environmental & Analysis sector's first half Return on Sales2 is expected to be lower due to mix effects.

By geography, the USA and Mainland Europe have delivered strong organic constant currency1 revenue growth, while the UK has grown modestly; together, these account for nearly 80% of Group revenue. Organic constant currency1 revenue performance in Asia Pacific was negative, reflecting declines in China, partially offset by a strong performance in Australasia.

The appreciation of Sterling is having a negative currency translation effect on the Group's results; we expect this effect to continue in the second half of the year6.

Further progress in M&A; healthy acquisition pipeline

Following a record acquisition spend in the 2023 financial year, with seven acquisitions completed for a maximum total consideration of £397m, we made three acquisitions in the first half of this financial year for a maximum total consideration of £80m. We have a healthy acquisition pipeline across all three sectors.

We continue to actively manage our portfolio of global businesses to ensure that it continues to deliver strong growth and returns and is aligned with our purpose of growing a safer, cleaner, healthier future for everyone, every day. We made one small disposal, of our 70% stake in FireMate Software Pty. Ltd. (FireMate), for a total consideration of AUD8.4m (£4.3m), of which AUD2.1m (£1.1m) is deferred. Halma will retain FireMate's Nimbus digital solution that enables remote connectivity for fire and evacuation systems.

In our Environmental & Analysis sector, we acquired Visual Imaging Resources LLC as a bolt-on to Minicam in April and Sewertronics Sp. Z o.o. as a standalone company in May; details of these acquisitions were previously reported in our Full Year 2023 results released in June. In August, we acquired Lazer Safe Pty. Ltd., an Australia-based designer and manufacturer of safety solutions for industrial press brake applications, for AUD45m (approximately £23m) on a cash and debt free basis, as a standalone company within the Safety sector.

Half Year Results

The results for the half year ending 30 September 2023 will be released on Thursday 16 November 2023.

For further information, please contact:

Halma plc

Marc Ronchetti, Group Chief Executive +44 (0)1494 721111

Steve Gunning, Chief Financial Officer

Charles King, Head of Investor Relations +44 (0) 7776 685948

Clayton Hirst, Director of Corporate Affairs +44 (0) 7384 796 013

MHP Communications

Oliver Hughes / Rachel Farrington / Ollie Hoare +44 (0)20 3128 8622 / 8613 / 8276

Notes:

1. Organic constant currency measures exclude the effect of movements in foreign exchange rates on the translation of revenue and profit into Sterling, as well as acquisitions in the year following completion and disposals.

2. Return on Sales is defined as Adjusted profit before taxation4 from continuing operations expressed as a percentage of revenue from continuing operations.

3. The following guidance was given in our Full Year 2023 results announcement in June 2023: "Based on current market conditions, we expect to deliver good organic constant currency1 revenue growth in the year ahead, and Return on Sales2 to increase to approximately 20%."

4. Adjusted profit before taxation is before amortisation and impairment of acquired intangible assets, acquisition items, and profit or loss on disposal of businesses.

5. In the five financial years from 2016/17 to 2020/21, Halma delivered on average 48% of its annual revenue in the first half of the year, and 45% of its Adjusted profit before taxation4.

6. Sterling has strengthened in the year relative to many currencies, including the US Dollar and Euro. If current exchange rates continue throughout the rest of the current financial year, the currency translation impact on the Group's results is expected to be negative. Based on exchange rates of Sterling/US Dollar 1:1.26 and Sterling/Euro 1:1.17, we would expect approximately a £55m negative revenue effect and approximately a £13m negative profit effect in the 2024 financial year, compared to the 2023 financial year, of which approximately 30% would occur in the first half of the financial year.

7. This Trading Update is based upon unaudited management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

8. A copy of this announcement, together with other information about Halma, may be viewed on its website at www.halma.com.

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad market areas where it operates:

· Safety - Protecting people's safety and the environment as populations grow, and enhancing worker safety.

· Environment - Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.

· Health - Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

Halma employs over 8,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

Halma has been named as one of Britain's Most Admired Companies for the past five years.

For more information www.halma.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSESFUSEDSEDU
Date   Source Headline
2nd Apr 20151:00 pmRNSDirectorate Change
1st Apr 20154:50 pmRNSTotal Voting Rights
30th Mar 20152:53 pmRNSHolding(s) in Company
17th Mar 20152:48 pmRNSTransaction in Own Shares
5th Mar 20152:00 pmRNSInvestor Event
2nd Mar 20153:37 pmRNSTotal Voting Rights
18th Feb 201512:09 pmRNSTransaction in Own Shares
12th Feb 201511:26 amRNSHolding(s) in Company
11th Feb 20154:39 pmRNSDirector/PDMR Shareholding
10th Feb 20157:00 amRNSTrading Update
2nd Feb 20154:19 pmRNSTotal Voting Rights
21st Jan 20153:06 pmRNSDirector/PDMR Shareholding
14th Jan 20154:42 pmRNSTransaction in Own Shares
14th Jan 20152:56 pmRNSTreasury Stock
6th Jan 20153:23 pmRNSBlocklisting Interim Review
2nd Jan 20157:00 amRNSTotal Voting Rights
23rd Dec 20147:05 amRNSDirector Declaration
17th Dec 20145:23 pmRNSTreasury Stock
1st Dec 20142:08 pmRNSTotal Voting Rights
21st Nov 20141:12 pmRNSTreasury Stock
20th Nov 20143:47 pmRNSDirector/PDMR Shareholding
18th Nov 20145:05 pmRNSDoc re. Half Yearly Report
18th Nov 20147:00 amRNSHalf Yearly Report
3rd Nov 20144:42 pmRNSTotal Voting Rights and Treasury Stock
9th Oct 20144:40 pmRNSHolding(s) in Company
2nd Oct 20145:29 pmRNSDirector/PDMR Shareholding
2nd Oct 20145:27 pmRNSDirector Declaration
1st Oct 20143:49 pmRNSTotal Voting Rights
29th Sep 20144:34 pmRNSTreasury Stock
11th Sep 20143:51 pmRNSTreasury Stock
9th Sep 20141:05 pmRNSHolding(s) in Company
4th Sep 20149:26 amRNSHolding(s) in Company
3rd Sep 20145:17 pmRNSDirector/PDMR Shareholding
1st Sep 20143:14 pmRNSTotal Voting Rights
13th Aug 20149:00 amRNSDirector/PDMR Shareholding
11th Aug 20147:00 amRNSBoard Change
1st Aug 20143:48 pmRNSTotal Voting Rights
25th Jul 20145:48 pmRNSResult of AGM
24th Jul 20147:00 amRNSInterim Management Statement
23rd Jul 20149:45 amRNSTreasury Stock
1st Jul 20141:52 pmRNSTotal Voting Rights
1st Jul 201411:26 amRNSBlocklisting Interim Review
25th Jun 20143:20 pmRNSDirector/PDMR Shareholding
24th Jun 20149:48 amRNSAnnual Financial Report
18th Jun 20143:34 pmRNSAdditional Listing
12th Jun 20147:00 amRNSFinal Results
11th Jun 20141:00 pmRNSBoard changes
2nd Jun 20142:51 pmRNSTotal Voting Rights
2nd Jun 20147:00 amRNSAcquisition and Disposal
27th May 201412:08 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.